Search for: "Stanton v. Commissioner" Results 1 - 20 of 22
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Jul 2012, 3:35 am
For example, in Stanton v Board of Trustees, 550 NYS2d 16, the Appellate Division ruled that Stanton was not deprived of administrative due process even though members of the Board who voted to terminate Stanton also participated in the underlying investigation that lead to charges of misconduct being brought against her. [read post]
7 Jul 2008, 9:36 pm
Related documents: Viacom v. [read post]
16 Sep 2008, 4:45 am
For example, in Stanton v Board of Trustees, 550 NYS2d 16, the Appellate Division ruled that Stanton was not deprived of administrative due process even though members of the Board who voted to terminate Stanton also participated in the underlying investigation that lead to charges of misconduct being brought against her. [read post]
6 Oct 2008, 2:11 pm
Commissioner of Internal Revenue testing whether a specific legal formula, or the facts of individual cases, controls he value of property for federal estate tax purposes (Commissioner v. [read post]
4 Oct 2023, 7:29 am by Norman L. Eisen
FEC Case Dissent from Dismissal Commissioners’ Statement of Reasons (May 6, 2021) Federal Election Commission, Michael Cohen et al. [read post]
1 Feb 2024, 7:00 am by Norman L. Eisen
FEC Case Dissent from Dismissal Commissioners’ Statement of Reasons (May 6, 2021) Federal Election Commission, Michael Cohen et al. [read post]
18 Sep 2008, 8:56 pm
Opinion below (7th Circuit) Petition for certiorari Brief in opposition Petitioner’s reply __________________ Docket: 07-1366 Case name: Stanton, et al. v. [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its… [read post]
9 Mar 2020, 1:21 pm by Unknown
FDA and FTC Approaches to Help Ensure Truthful and Non‐misleading Advertising and Promotional Communications Lowell Schiller, Principal Associate Commissioner for Policy, FDA: have seen troubling communications suggesting biosimilars are less safe/less effective than reference products or that there may be clinically meaningful differences b/t them when biosimilars can’t be approved unless there are no clinically meaningful differences. [read post]